New needle-free HPV vaccine increases effectiveness, availability in developing world
2010-11-18
(Press-News.org) Arlington, Va. — New research being presented at the 2010 FIP Pharmaceutical Sciences World Congress in association with the American Association of Pharmaceutical Scientists Annual Meeting and Exposition will highlight a targeted inhalable dry powder vaccine that may prove preferable in terms of needle avoidance and expected lower cost than the current commercial human papillomavirus (HPV) vaccine used throughout the world.
HPV is the number one cause of cervical cancer, which is the second most common cancer in women around the globe. According to the World Health Organization, nearly a quarter of a million women die each year from cervical cancer, 80 percent of them in developing countries.
Lead researcher David McAdams and colleagues from the University of Colorado at Boulder created a dry powder that goes directly to the mucous membranes in the respiratory tract or mouth. Since HPV is a disease that affects the mucous membranes, the powder is more targeted. "Imagine the vaccine as a car," said McAdams. "Using this delivery method is similar to parking in your driveway instead of driving around the block a few times to find a spot."
The dry powder has added benefits for developing countries. For example, the current HPV vaccine is delivered by a needle injection, which is highly susceptible to contamination. The powder, as a solid, rather than a frozen liquid, may be more stable than current HPV vaccines, which makes it easier to store and transport in developing countries.
"While there are effective HPV vaccines on the market, cost, refrigeration and needle disposal shorten the reach they have," commented McAdams. "Our goal is to develop an economical, safe and easily administered HPV vaccine for everyone."
For the first time, FIP's PSWC and the AAPS Annual Meeting and Exposition will join to hold the world's largest pharmaceutical sciences meeting to improve global health through advances in pharmaceutical sciences. An estimated 10,000 scientists from more than 60 countries will participate in 100 sessions, including 40 symposia and roundtables.###
Learn more about the meeting and global health from leading scientists in this webisode series and follow the tweet hashtag #PSWC2010 for meeting updates.
Editor's Note: All press must register and provide press credentials to attend this meeting. To register, please contact CatapanoJ@aaps.org or 703-248-4772. To schedule an interview with David McAdams or any other press inquiry, please contact Hillarie Turner at hbt@ecius.net or 202-296-2002 x113.
About AAPS: The American Association of Pharmaceutical Scientists is a professional, scientific society of approximately 12,000 members employed in academia, industry, government and other research institutes worldwide. For more information, please visit www.aapspharmaceutica.com.
About FIP: The International Pharmaceutical Federation is the global federation of national associations representing two million pharmacists and pharmaceutical scientists from around the world. For more information, please visit www.fip.org.
END
ELSE PRESS RELEASES FROM THIS DATE:
2010-11-18
Post-traumatic stress disorder (PTSD) more than doubles a veteran's risk of death from any cause and is an independent risk factor for cardiovascular disease, according to research presented at the American Heart Association's Scientific Sessions 2010.
PTSD is more than a psychological disorder, and the study suggests that physicians should provide early and aggressive evaluation and treatment of cardiovascular risk factors in patients with PTSD, said Naser Ahmadi, M.D., M.S., and Ramin Ebrahimi, M.D., co-principal investigators of the study. PTSD is a cluster of symptoms ...
2010-11-18
9 a.m. Abstract 20649 – Some ICD recipients may not get optimal medical therapy
Guidelines recommending optimal medical therapy are not always followed for patients receiving implantable cardioverter-defibrillators (ICDs), a new study found.
Researchers examined optimal medical therapy — beta blocker and angiotensin converting enzyme inhibitor (ACEI)/angiotensin II receptor blocker (ARB) at discharge — among ICD patients with ejection fractions below 35 percent. Of the 231,725 patient stays analyzed, 73.1 percent of the patients received optimal medical therapy at ...
2010-11-18
Cardiac stem cells — even in elderly and sick patients — could generate new heart muscle and vessel tissue and be used to treat heart failure, according to research presented at the American Heart Association's Scientific Sessions 2010.
Scientists surgically removed tissue from the muscular wall of the heart's chambers in 21 patients. They then isolated and multiplied the cardiac stem cells (CSCs) found there. Most of the patients had ischemic cardiomyopathy (enlarged and weakened muscle due to coronary artery disease). Eleven also had diabetes. The average age of patients ...
2010-11-18
San Diego -- Researchers from Georgetown University Medical Center's departments of neuroscience, pharmacology, physiology, biochemistry, molecular and cellular biology, and the interdisciplinary program of neuroscience will present more than 50 research abstracts at the 40th Annual Meeting of the Society for Neuroscience Nov. 13th through the 17th in San Diego.
Modulation of temporal relationships between default mode and task-positive networks by the dopamine transporter genotype during working memory and the resting state
Session: Imaging Human Memory Function
Abstract/Poster: ...
2010-11-18
Two separate discoveries by researchers at the University of Wisconsin-Milwaukee (UWM) offer potential for development of a first-ever pharmacological treatment for cocaine addiction.
In one study, a common beta blocker, propranolol, currently used to treat hypertension and anxiety, has shown to be effective in preventing the brain from retrieving memories associated with cocaine use in animal-addiction models, according to Devin Mueller, UWM assistant professor of psychology and a co-author with James Otis of the research.
The work was presented today at the annual ...
2010-11-18
COLUMBUS, Ohio – Exposure to even dim light at night is enough to cause physical changes in the brains of hamsters that may be associated with depression, a new study shows.
Researchers found that female Siberian hamsters exposed to dim light every night for eight weeks showed significant changes in a part of the brain called the hippocampus.
This is the first time researchers have found that light at night, by itself, may be linked to changes in the hippocampus.
These alterations may be a key reason why the researchers also found that the hamsters exposed to dim ...
2010-11-18
Widely prescribed for their cholesterol-lowering properties, recent clinical research indicates that statins can produce a second, significant health benefit: lowering the risk of severe bacterial infections such as pneumonia and sepsis. A new explanation for these findings has been discovered by researchers at the University of California, San Diego School of Medicine and Skaggs School of Pharmacy & Pharmaceutical Sciences, who describe for the first time how statins activate the bacterial killing properties of white blood cells.
The research is published in the November ...
2010-11-18
Being able to read and understand words like anemia, hormones and seizure means a patient with heart failure may be less likely to be hospitalized, according to a new study from Emory University School of Medicine. Findings will be presented Nov. 17 at the American Heart Association Scientific Sessions conference in Chicago.
The research, led by Emory cardiologist Javed Butler, MD, MPH, professor of medicine, Emory School of Medicine and director of Heart Failure Research at Emory Healthcare, involved the use of a simple test called the Rapid Estimates of Adults Literacy ...
2010-11-18
When cardiac or skeletal muscle is not receiving enough oxygen to meet metabolic demands, a person will experience pain, such as angina, chest pain during a heart attack, or leg pain during a vigorous sprint. This type of pain is called "ischemic" pain and is sensed in the body by receptors on sensory neurons. It has been suggested that lactic acid, which increases during muscle exertion under conditions where oxygen is low, is a potential mediator of ischemic pain via action at acid sensing channel #3 (ASIC3). However, the acid signal it generates is quite subtle and is ...
2010-11-18
SANTA CLARA, Calif. – Embargoed for 2 p.m. EST, November 17, 2010 – Global ophthalmic device company OptiMedica Corp. has announced that results from a clinical study of its Catalys Precision Laser System were published in the peer-reviewed journal Science Translational Medicine ("Femtosecond Laser-Assisted Cataract Surgery with Integrated Optical Coherence Tomography," Volume 2, Issue 58, November 17, 2010). The data showed that, when compared to manual techniques, the Catalys Precision Laser System helped surgeons achieve significant improvement in precision during several ...
LAST 30 PRESS RELEASES:
[Press-News.org] New needle-free HPV vaccine increases effectiveness, availability in developing world
